WHWK (STOCKS)
Whitehawk Therapeutics, Inc. Common Stock
$3.470000
+0.080000 (+2.36%)
Prev close: $3.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David Lennon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $164.01M
- Employees
- 21
- P/E (TTM)
- 7.14
- P/B (TTM)
- 1.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.34 | $-0.16 | -0.1829 | -116.42% |
|
Sep 2025 (Q3)
|
$-0.26 | $0.07 | -0.3280 | -482.35% |
|
Jun 2025 (Q2)
|
$-0.76 | $0.50 | -1.2632 | -251.03% |
|
Mar 2025 (Q1)
|
$-0.37 | $-0.47 | +0.0992 | +21.14% |
Financial Statements
| Revenues | $7.15M |
| Benefits Costs and Expenses | $27.74M |
| Cost Of Revenue | $760.00K |
| Costs And Expenses | $121.55M |
| Gross Profit | $6.39M |
| Operating Expenses | $120.79M |
| Selling, General, and Administrative Expenses | $29.82M |
| Research and Development | $90.96M |
| Operating Income/Loss | -$114.40M |
| Income/Loss From Continuing Operations After Tax | -$20.60M |
| Income/Loss From Continuing Operations Before Tax | -$20.60M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$20.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.33 |
| Diluted Earnings Per Share | -$0.33 |
| Basic Average Shares | 61,886,765 |
| Diluted Average Shares | 61,886,765 |
| Assets | $150.83M |
| Current Assets | $149.01M |
| Cash | $145.70M |
| Inventory | $0.00 |
| Other Current Assets | $3.31M |
| Noncurrent Assets | $1.82M |
| Fixed Assets | $3.00K |
| Other Non-current Assets | $1.81M |
| Liabilities | $14.52M |
| Current Liabilities | $14.52M |
| Accounts Payable | $917.00K |
| Other Current Liabilities | $13.60M |
| Noncurrent Liabilities | $0.00 |
| Equity | $136.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $136.31M |
| Liabilities And Equity | $150.83M |
| Net Cash Flow From Operating Activities | -$97.43M |
| Net Cash Flow From Operating Activities, Continuing | -$97.43M |
| Net Cash Flow From Investing Activities | $11.89M |
| Net Cash Flow From Investing Activities, Continuing | $11.89M |
| Net Cash Flow From Financing Activities | $94.38M |
| Net Cash Flow From Financing Activities, Continuing | $94.38M |
| Net Cash Flow | $8.83M |
| Net Cash Flow, Continuing | $8.83M |
| Comprehensive Income/Loss | -$20.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.49M |
| Other Comprehensive Income/Loss | -$20.49M |